266 related articles for article (PubMed ID: 34818088)
21. Pharmacologic treatment of hand-, knee- and hip-osteoarthritis.
Bobacz K
Wien Med Wochenschr; 2013 May; 163(9-10):236-42. PubMed ID: 23715933
[TBL] [Abstract][Full Text] [Related]
22. Complexities in the pharmacologic management of osteoarthritis pain.
McCarberg B; Tenzer P
Curr Med Res Opin; 2013 May; 29(5):539-48. PubMed ID: 23489409
[TBL] [Abstract][Full Text] [Related]
23. Australian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis.
Basedow M; Williams H; Shanahan EM; Runciman WB; Esterman A
BMC Res Notes; 2015 Oct; 8():536. PubMed ID: 26438323
[TBL] [Abstract][Full Text] [Related]
24. Celecoxib for osteoarthritis.
Puljak L; Marin A; Vrdoljak D; Markotic F; Utrobicic A; Tugwell P
Cochrane Database Syst Rev; 2017 May; 5(5):CD009865. PubMed ID: 28530031
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
Karlsson M; Berggren AC
Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
[TBL] [Abstract][Full Text] [Related]
27. The use of opioids in the treatment of osteoarthritis: when, why, and how?
Goodwin JL; Kraemer JJ; Bajwa ZH
Curr Pain Headache Rep; 2005 Dec; 9(6):390-8. PubMed ID: 16282039
[TBL] [Abstract][Full Text] [Related]
28. Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study.
Li L; Marozoff S; Lu N; Xie H; Kopec JA; Cibere J; Esdaile JM; Aviña-Zubieta JA
Arthritis Res Ther; 2022 Apr; 24(1):85. PubMed ID: 35410440
[TBL] [Abstract][Full Text] [Related]
29. Treatment satisfaction after switching to another therapy in Spanish orthopaedic clinic outpatients with knee or hip osteoarthritis previously refractory to paracetamol.
Oteo-Álvaro A; Marín MT; Ruiz-Ibán MA; Armada B; Rejas J
Clin Drug Investig; 2012 Oct; 32(10):685-95. PubMed ID: 22861523
[TBL] [Abstract][Full Text] [Related]
30. Drug utilization, clinical and economic outcomes of patients with osteoarthritis of the hip and/or knee treated with long-term use of traditional NSAIDs, topical NSAIDs, and COX-2 inhibitors.
Silverman SL; Schepman P; Rice JB; Beck CG; Johnson M; White A; Robinson RL; Emir B
Curr Med Res Opin; 2022 Jul; 38(7):1153-1166. PubMed ID: 35575236
[TBL] [Abstract][Full Text] [Related]
31. Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019.
Ebata-Kogure N; Murakami A; Nozawa K; Fujii K; Lin Y; Ushida T; Kikuchi S
Clin Drug Investig; 2020 Nov; 40(11):1071-1084. PubMed ID: 32965598
[TBL] [Abstract][Full Text] [Related]
32. Topical NSAIDs for chronic musculoskeletal pain in adults.
Derry S; Conaghan P; Da Silva JA; Wiffen PJ; Moore RA
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD007400. PubMed ID: 27103611
[TBL] [Abstract][Full Text] [Related]
33. Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial.
Ishijima M; Nakamura T; Shimizu K; Hayashi K; Kikuchi H; Soen S; Omori G; Yamashita T; Uchio Y; Chiba J; Ideno Y; Kubota M; Kurosawa H; Kaneko K;
Arthritis Res Ther; 2014 Jan; 16(1):R18. PubMed ID: 24443804
[TBL] [Abstract][Full Text] [Related]
34. Acetaminophen for osteoarthritis.
Towheed TE; Maxwell L; Judd MG; Catton M; Hochberg MC; Wells G
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004257. PubMed ID: 16437479
[TBL] [Abstract][Full Text] [Related]
35. Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs.
Cao Z; Zhou J; Long Z; Li Y; Sun J; Luo Y; Wang W
Aging (Albany NY); 2020 Dec; 13(1):1051-1070. PubMed ID: 33293475
[TBL] [Abstract][Full Text] [Related]
36. The use of opioids in the treatment of osteoarthritis: when, why, and how?
Goodwin JL; Kraemer JJ; Bajwa ZH
Curr Rheumatol Rep; 2009 Feb; 11(1):5-14. PubMed ID: 19171106
[TBL] [Abstract][Full Text] [Related]
37. Viscosupplementation: managed care issues for osteoarthritis of the knee.
Arnold W; Fullerton DS; Holder S; May CS
J Manag Care Pharm; 2007 May; 13(4 Suppl):S3-19; quiz S20-2. PubMed ID: 23631049
[TBL] [Abstract][Full Text] [Related]
38. Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain.
Rejas-Gutierrez J; Sicras-Mainar A; Darbà J
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211010599. PubMed ID: 33995603
[TBL] [Abstract][Full Text] [Related]
39. Treatment of pain in osteoarthritis.
Pavelka K
Eur J Pain; 2000; 4 Suppl A():23-30. PubMed ID: 11310479
[TBL] [Abstract][Full Text] [Related]
40. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study.
Silverfield JC; Kamin M; Wu SC; Rosenthal N;
Clin Ther; 2002 Feb; 24(2):282-97. PubMed ID: 11911558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
